The global Infectious disease diagnostics market is expected to grow during the forecast period owing to the increasing prevalence of various infectious diseases such as, malaria, TB, HIV/AIDS, hepatitis, HAIs, STDs and diarrheal diseases. The other vital drivers of this market are growing demand of rapid diagnostic technique over current technique due to long turnaround time and supportive government funding. The various methods used for diagnosis are microbiological techniques, intensive care medicine and clinical laboratory techniques
Infectious disease diagnostics market is segmented on the basis of product, technology, and application. On the basis of technology, the market is bifurcated into, molecular and traditional diagnostic technique. Further, molecular diagnostic technique is classified into INAAT (Isothermal Nucleic Acid Amplification Test), Polymerase Chain Reaction (PCR), NGS & DNA sequencing, hybridization and microarrays. Traditional diagnostic technique is classified into biochemical characterization, microscopy and immunodiagnostics. Among these PCR and INAAT holds the larger market share. PCR is a reaction process through which multiple image of DNA is generated from a particular DNA sequence. On the basis of application, the infectious disease diagnostic market is bifurcated into, Hepatitis C, Hepatitis B, Tuberculosis (TB), Acquired Immunodeficiency Syndrome (AIDS), Human Papillomavirus (HPV), and Methicillin-resistant Staphylococcus Aureus (MRSA). Among these TB holds the larger market share. TB is generally caused by mycobacterium tuberculosis. On the basis of product, the market is classified into consumables (assays and reagents), software & services, and instruments & analyzers. Among these consumables held the largest market share as of 2013.
Geographically, infectious disease diagnostics market is studied with respect to four regions such as North America, Europe, Asia Pacific and RoW. Among these North America is dominating the whole region followed by Europe due to presence of large number of patient population, large amount of investment in this sector and healthcare infrastructure, and various government initiatives. Asia Pacific market is expected to have lucrative growth rate due to the high prevalence of infectious diseases, and patient awareness.
The major market players in infectious disease diagnostics market are Bio Mérieux SA, Roche Diagnostics, Abbott Laboratories, Thermo Fischer Scientific, Inc., Becton, Dickinson & Company, Bio-Rad Laboratories. Alere Inc, Danaher Corporation and Johnson and Johnson.
Avail customized purchase options to meet your exact research needs:
Get your queries resolved from an industry expert.
Design an exclusive study to serve your research needs.
A testimonial for service in the form of BBB "A" Accreditation.
Your personal and confidential information is safe and secure.
"The quality of research they have done for us has been excellent..."
The most common concern for the governments of all Covid-19 hit nations is the excruciating need to screen for and test large numbers of patients for possible Sars-Cov-2 infection. As a result, most of them are facing major shortages in the supply for diagnostic kits to test for the virus. Diagnostics virology entities are under immense pressure to provide reliable testing kits, and there is a surge in demand for in-vitro or point-of-care testing capacities by labs across a large number of countries. The report will account for Covid19 as a key market contributor.